Evimple – Accelerating Pharma Partnerships

Company profile:

Startup name: Evimple

Tagline: Accelerating Pharma Partnerships

Elevator Pitch: Evimple is an AI copilot for pharmaceutical business development that combines research, partner discovery, and market intelligence in one platform.

Pharma business development is broken – it’s slow, fragmented, and dependent on outdated databases.

Evimple is the AI copilot that replaces weeks of cross-department research and months of partner search with one intelligent platform. We combine AI-driven portfolio intelligence with verified warm industry contacts, helping pharma SMEs move from idea to deal in days, not quarters. We don’t give raw data – we deliver BD-ready decisions.

It helps pharma companies evaluate opportunities, identify portfolio gaps, and find verified CDMO, CRO, and licensing partners in days instead of months. The platform aggregates medical, patent, regulatory, and commercial data and converts it into BD-ready insights, recommendations, and structured reports.

Target Market: USA, EU

How will you make money?: Subscriptions

How much capital have you raised?: 10-50k

Website: https://evimple.com

City/Country: Luxembourg

AI-assisted summary:

Evimple is a Luxembourg-based startup that offers a B2B marketplace designed to expedite partnerships within the pharmaceutical industry. By connecting pharmaceutical companies with verified Contract Development and Manufacturing Organizations (CDMOs), Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), and licensors, Evimple aims to reduce the traditional six-month manual partner search process to mere minutes. (Source: https://app.dealroom.co/companies/evimple)

The Problem and Target Users

Pharmaceutical business development managers often face prolonged and fragmented processes when seeking suitable partners for licensing, development, manufacturing, and analysis. Traditional methods involve extensive networking, attendance at trade shows, and reliance on outdated directories, leading to inefficiencies and delays in bringing medicines to market. Evimple targets these professionals by offering a streamlined, digital solution to these challenges. (Source: https://www.linkedin.com/posts/evimple_pharma-businessdevelopment-cdmo-activity-7379442633393459200-lAqM)

The Product and Key Features

Evimple’s platform integrates various aspects of pharmaceutical business development into a single environment, offering:

• Verified Partner Profiles: Users can access up-to-date information on potential partners, ensuring reliability and trustworthiness. (Source: https://www.linkedin.com/posts/evimple_pharma-businessdevelopment-cdmo-activity-7379442633393459200-lAqM)
• Advanced Filtering Options: The platform provides over 200 filters, allowing users to refine searches based on technology, geography, capacity, and therapeutic area, thereby enhancing the precision of partner selection. (Source: https://app.dealroom.co/companies/evimple)
• Transparent Data: Evimple offers clear and comparable data, facilitating informed decision-making during the partner selection process. (Source: https://www.linkedin.com/posts/evimple_pharma-businessdevelopment-cdmo-activity-7379442633393459200-lAqM)
• AI-Driven Recommendations: An upcoming feature aims to leverage artificial intelligence to suggest optimal partnerships based on strategic and therapeutic alignment. (Source: https://www.linkedin.com/posts/evimple_pharma-businessdevelopment-cdmo-activity-7379442633393459200-lAqM)

Business Model, Pricing Signals, and Traction

While specific details about Evimple’s business model and pricing are not publicly disclosed, the platform’s value proposition suggests a subscription-based model targeting pharmaceutical companies seeking efficient partnership solutions. Evimple has participated in the Grace Berlin Accelerator 2025, indicating early-stage traction and support within the startup ecosystem. (Source: https://www.f6s.com/company/evimple)

Expert Take

Evimple addresses a significant bottleneck in pharmaceutical business development by digitizing and streamlining the partner search process. Its focus on verified data and advanced filtering positions it as a valuable tool for industry professionals. However, the platform’s success will depend on its ability to scale its database of partners and effectively implement AI-driven features to maintain a competitive edge.

Note: Information based on publicly available sources at the time of writing, and summarized by AI.